PFIZER INC Quarterly Return On Equity in % from Q4 2010 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Pfizer Inc quarterly/annual Return On Equity history and growth rate from Q4 2010 to Q3 2024.
  • Pfizer Inc Return On Equity for the quarter ending September 29, 2024 was 4.69 %, a 56% decline year-over-year.
  • Pfizer Inc annual Return On Equity for 2023 was 2.19 %, a 93.7% decline from 2022.
  • Pfizer Inc annual Return On Equity for 2022 was 35 %, a 16.3% increase from 2021.
  • Pfizer Inc annual Return On Equity for 2021 was 30.1 %, a 112% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 4.69 -5.96 -56% Jul 1, 2024 Sep 29, 2024
Q2 2024 -2.83 -24.9 -113% Apr 1, 2024 Jun 30, 2024
Q1 2024 -0.33 -31.1 -101% Jan 1, 2024 Mar 31, 2024
Q4 2023 2.19 -32.8 -93.7% Oct 2, 2023 Dec 31, 2023
Q3 2023 10.7 -24.3 -69.5% Jul 3, 2023 Oct 1, 2023
Q2 2023 22.1 -14.2 -39.1% Apr 3, 2023 Jul 2, 2023
Q1 2023 30.8 -1.81 -5.55% Jan 1, 2023 Apr 2, 2023
Q4 2022 35 +4.91 +16.3% Oct 3, 2022 Dec 31, 2022
Q3 2022 35 +7.08 +25.4% Jul 4, 2022 Oct 2, 2022
Q2 2022 36.2 +17.2 +90.4% Apr 4, 2022 Jul 3, 2022
Q1 2022 32.6 +16.3 +100% Jan 1, 2022 Apr 3, 2022
Q4 2021 30.1 +15.9 +112% Oct 4, 2021 Dec 31, 2021
Q3 2021 27.9 +16 +134% Jul 5, 2021 Oct 3, 2021
Q2 2021 19 -2.52 -11.7% Apr 5, 2021 Jul 4, 2021
Q1 2021 16.3 -8.11 -33.2% Jan 1, 2021 Apr 4, 2021
Q4 2020 14.2 -11.7 -45.3% Sep 28, 2020 Dec 31, 2020
Q3 2020 11.9 -14.2 -54.3% Jun 29, 2020 Sep 27, 2020
Q2 2020 21.6 +1.67 +8.4% Mar 30, 2020 Jun 28, 2020
Q1 2020 24.4 +7.05 +40.7% Jan 1, 2020 Mar 29, 2020
Q4 2019 25.9 +9.7 +60% Sep 30, 2019 Dec 31, 2019
Q3 2019 26.1 -7.42 -22.1% Jul 1, 2019 Sep 29, 2019
Q2 2019 19.9 -13.1 -39.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 17.3 -15.9 -47.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 16.2 -17.9 -52.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 33.6 +17.1 +104% Jul 2, 2018 Sep 30, 2018
Q2 2018 33 +19.2 +139% Apr 2, 2018 Jul 1, 2018
Q1 2018 33.2 +21.3 +179% Jan 1, 2018 Apr 1, 2018
Q4 2017 34.1 +22.5 +195% Oct 2, 2017 Dec 31, 2017
Q3 2017 16.5 +6.63 +67.4% Jul 3, 2017 Oct 1, 2017
Q2 2017 13.8 +2.93 +26.9% Apr 3, 2017 Jul 2, 2017
Q1 2017 11.9 +0.29 +2.5% Jan 1, 2017 Apr 2, 2017
Q4 2016 11.6 +1.12 +10.7% Oct 3, 2016 Dec 31, 2016
Q3 2016 9.83 -2.39 -19.5% Jul 4, 2016 Oct 2, 2016
Q2 2016 10.9 -1.6 -12.8% Apr 4, 2016 Jul 3, 2016
Q1 2016 11.6 -0.86 -6.9% Jan 1, 2016 Apr 3, 2016
Q4 2015 10.4 -1.55 -12.9% Sep 28, 2015 Dec 31, 2015
Q3 2015 12.2 -1.29 -9.54% Jun 29, 2015 Sep 27, 2015
Q2 2015 12.5 -0.92 -6.86% Mar 30, 2015 Jun 28, 2015
Q1 2015 12.5 -15.2 -54.9% Jan 1, 2015 Mar 29, 2015
Q4 2014 12 -15.8 -56.9% Sep 29, 2014 Dec 31, 2014
Q3 2014 13.5 -18.5 -57.8% Jun 30, 2014 Sep 28, 2014
Q2 2014 13.4 -19 -58.6% Mar 31, 2014 Jun 29, 2014
Q1 2014 27.7 +8.65 +45.5% Jan 1, 2014 Mar 30, 2014
Q4 2013 27.8 +9.98 +56.1% Sep 30, 2013 Dec 31, 2013
Q3 2013 32 +20.2 +171% Jul 1, 2013 Sep 29, 2013
Q2 2013 32.4 +20.3 +167% Apr 1, 2013 Jun 30, 2013
Q1 2013 19 +7.93 +71.6% Jan 1, 2013 Mar 31, 2013
Q4 2012 17.8 +6.45 +56.8% Oct 1, 2012 Dec 31, 2012
Q3 2012 11.8 -0.99 -7.74% Jul 2, 2012 Sep 30, 2012
Q2 2012 12.1 +2.49 +25.8% Apr 2, 2012 Jul 1, 2012
Q1 2012 11.1 +1.52 +15.9% Jan 1, 2012 Apr 1, 2012
Q4 2011 11.4 +2 +21.4% Oct 3, 2011 Dec 31, 2011
Q3 2011 12.8 Jul 4, 2011 Oct 2, 2011
Q2 2011 9.65 Apr 4, 2011 Jul 3, 2011
Q1 2011 9.56 Jan 1, 2011 Apr 3, 2011
Q4 2010 9.35 Oct 4, 2010 Dec 31, 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.